Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors

BACKGROUND: Implementation of personalized medicine requires the accessibility of tumor molecular profiling in order to allow prioritization of appropriate targeted therapies for individual patients. Our aim was to study the role of comprehensive genomic profiling assays that may inform treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Masayuki, Takahama, Takayuki, Sakai, Kazuko, Shimizu, Shigeki, Watanabe, Satomi, Kawakami, Hisato, Tanaka, Kaoru, Sato, Chihiro, Hayashi, Hidetoshi, Nonagase, Yoshikane, Yonesaka, Kimio, Takegawa, Naoki, Okuno, Tatsuya, Yoshida, Takeshi, Fumita, Soichi, Suzuki, Shinichiro, Haratani, Koji, Saigoh, Kazumasa, Ito, Akihiko, Mitsudomi, Tetsuya, Handa, Hisashi, Fukuoka, Kazuya, Nakagawa, Kazuhiko, Nishio, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018334/
https://www.ncbi.nlm.nih.gov/pubmed/33325566
http://dx.doi.org/10.1002/onco.13639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018334/
https://www.ncbi.nlm.nih.gov/pubmed/33325566
http://dx.doi.org/10.1002/onco.13639

Ejemplares similares